Form 8-K · Current report
Centene Corporation 8-K, filed Sep 16, 2026
- Filed
- CIK
- 0001071739
- Accession no.
- 0001071739-26-000172
Summary
Centene Corporation reaffirmed its full-year 2026 guidance — GAAP diluted EPS of greater than $3.11 and adjusted diluted EPS of greater than $4.80 — during management's participation at the Deutsche Bank 2026 Healthcare Summit on September 16, 2026, with further investor discussions planned through the week of September 21. The company also disclosed non-GAAP financial measures and forward-looking statement caveats in the filing.
Key points
- Centene management is participating at the Deutsche Bank 2026 Healthcare Summit on September 16, 2026 at 9:00 a.m. EDT, with a simultaneous live audio webcast and a replay available on the company's website.
- Centene reaffirmed full-year 2026 GAAP diluted EPS guidance of greater than $3.11 and adjusted diluted EPS guidance of greater than $4.80.
- Discussions with investors on business and financial results are expected to continue through the week of September 21.
- Centene states the non-GAAP measures exclude amortization of acquired intangible assets, acquisition and divestiture related expenses, and other items, and may differ from similar measures used by other companies.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
From the filing
ITEM 7.01 REGULATION FD DISCLOSURE Centene Corporation (the Company) will be participating at the Deutsche Bank 2026 Healthcare Summit on Wednesday, September 16, 2026, at 9:00 a.m. EDT. During the conference, and in subsequent discussions with investors continuing through the week of September 21, members of management will discuss the Company's business and financial results, including reaffirming its full year 2026 GAAP diluted earnings per share (EPS) guidance of greater than $3.11 and its full year adjusted diluted EPS guidance of greater than $4.80. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.